Boothbay Fund Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Boothbay Fund Management’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-83,454	Closed	-$527K	–	2665
2022 Q4	$527K	Buy	83,454 +2,141	+3%	+$11.9K	0.01%	1161
2022 Q3	$416K	Buy	+81,313	New	+$511K	0.01%	1335
2019 Q2	–	Sell	-2,685	Closed	-$113K	–	944
2019 Q1	$113K	Hold	2,685	–	–	0.01%	652
2018 Q4	$112K	Buy	+2,685	New	+$121K	0.02%	549

Boothbay Fund Management's FSTX Position: Q1 2023 in Review

Boothbay Fund Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 83,454 shares — an estimated $527K sold.

Boothbay Fund Management first reported a position in FSTX in Q4 2018 and held it in 4 quarters. The position peaked at $527K in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

Boothbay Fund Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Boothbay Fund Management sold 83,454 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $527K.
Boothbay Fund Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2018 and held it in 4 quarters.
Boothbay Fund Management's F-star Therapeutics, Inc. Common Stock position peaked at $527K in Q4 2022.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Boothbay Fund Management's 13F filing for Q1 2023, filed 15 May 2023.